RxSight, Inc.
- RXST
- NASDAQ
- Medical devices
- Intraocular Lenses (Cataract Surgery)
- Ophthalmic Medical Devices
$4.51
Today −3.43%Quote Oct 16, 2026, 08:00 PM UTC
−15.23%over the last month
Max drawdown −15.2%From 1-month high −15.2%3 months −19.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$187.6M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$7.31
+62.1% from here
Floor
$4.48
0.7% below price
Where the price sits
12 analysts
Analyst range, low to high
$5.50$11.00
- Price $4.51
- Resistance $4.62
- Consensus $7.31
The price is just above its floor and right under resistance. Analysts' average target sits about 62% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RXSTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $33.7M
- Service Warranty Service Contracts And Accessories$1.4M4.2%
- L D D$1.3M4.0%
- Other / not reported$31.0M91.9%
Industry
Medical devices
Employees
461
Founded
1997